Elecsys Troponin T hs Gen 6
JSON twin: https://www.healthaidb.com/software/elecsys-troponin-t-hs-gen-6.json
Company Name
Roche
Product URL
https://diagnostics.roche.com/global/en/products/lab/elecsys-troponin-t-hs-gen-6-pid00001103.html
Company URL
https://www.roche.com
Categories
Summary
Elecsys Troponin T hs Gen 6 is a high-sensitivity assay developed by Roche for the rapid and accurate diagnosis of acute myocardial infarction (heart attack).
Description
The Elecsys Troponin T hs Gen 6 assay enables clinicians to detect even the smallest changes in troponin levels, a critical biomarker for diagnosing acute myocardial infarction (AMI). It offers high precision and accuracy, with a 9-minute turnaround time for STAT assays, and demonstrates robustness with low lot-to-lot and platform variability. The assay has been globally validated through the TSIX study program, establishing a standardized diagnostic cutoff across diverse populations and settings. Additionally, it exhibits 10 times more resistance to interferences from hemoglobin, reducing the need for resampling. The assay is compatible with various Roche analyzers and complies with current regulatory standards, enhancing traceability and confidence in results.
Api Available
no
Certifications
- FDA 510(k)
- Clinical and Laboratory Standards Institute (CLSI) EP17-A2
- Clinical and Laboratory Standards Institute (CLSI) EP05-A2
Company Founding
1896
Company Offices
Compliance
- FDA approval
- Clinical and Laboratory Standards Institute (CLSI) EP17-A2
- Clinical and Laboratory Standards Institute (CLSI) EP05-A2
Customers
Data Residency
EU-only
Data Standards
- IFCC high-sensitivity criteria
- FDA approval standards
- Regulatory compliance standards
- Clinical and Laboratory Standards Institute (CLSI) EP17-A2
- Clinical and Laboratory Standards Institute (CLSI) EP05-A2
Deployment Model
Features
- High precision and accuracy for confident decision making
- High sensitivity at even lower troponin levels for accurate, timely results
- Exceeds latest high-sensitivity IFCC criteria
- 10x more resistance to interferences from hemoglobin
- Low lot-to-lot and platform variability
- 3-level quality control
- Long-term compliance with current regulatory standards
- Global validation for consistent cardiac assessment worldwide
- Standardized interpretation of troponin results across diverse populations
- Compatible with various analyzers and settings
- Supports rapid decision-making in acute myocardial infarction diagnosis
- Enhances triage efficiency in emergency care
- Provides life-saving care at the earliest opportunity
- Offers a 30-year legacy in troponin innovation
- First to receive FDA approval for high-sensitivity troponin tests
- Enables detection of even the smallest changes in troponin levels
- Supports clinicians in timely and accurate diagnosis
- Improves patient outcomes in acute coronary syndrome cases
- Reduces need for resampling due to hemoglobin interference resistance
- Demonstrates robustness and reproducibility across different platforms
Id
SW2558
Integration Partners
Integrations
- Cobas e 411 analyzer
- Cobas e 601 analyzer
- Modular analytics serum work areas
- Cobas h232 analyzer
- Cobas e 801 analyzer
- Cobas e 602 analyzer
Languages Supported
- English
- German
- French
- Spanish
- Italian
- Dutch
- Portuguese
- Russian
- Chinese
- Japanese
- Korean
- Arabic
- Hindi
- Bengali
- Punjabi
- Telugu
- Marathi
- Tamil
- Urdu
- Gujarati
Last Updated
2025-10-11
License
commercial
Market Segment
Optional Modules
- 3-level quality control module
- Global validation study module
- Hemoglobin interference resistance enhancement module
- Regulatory compliance tracking module
- Platform variability analysis module
- Acute myocardial infarction diagnostic support module
- Triage efficiency improvement module
- FDA approval tracking module
- Troponin level detection enhancement module
- Patient outcome improvement module
Os Platforms
Pricing Details
Contact Roche for pricing information.
Pricing Model
enterprise_quote
Privacy Features
- Data anonymization
- Data minimization
- User consent management
- Data access controls
- Data retention policies
- Compliance with privacy regulations
- Secure data storage
- Data sharing policies
- User data rights management
- Data breach notification procedures
Product Code
SW2558
Product Name
Elecsys Troponin T hs Gen 6
Ratings
Regions Available
Related Urls
Release Year
2025
Security Features
- Data encryption
- Access control
- Audit trails
- User authentication
- Data integrity checks
- Compliance with regulatory standards
- Secure data transmission
- Data backup and recovery
- User role management
- System monitoring
Specialties
Support Channels
System Requirements
Cobas e 411 analyzer, Cobas e 601 analyzer, Modular analytics serum work areas, Cobas h232 analyzer, Cobas e 801 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer, Cobas e 601 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer, Cobas e 601 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer, Cobas e 601 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer
Target Users
- clinicians
- laboratory technicians
- emergency department staff
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "Elecsys Troponin T hs Gen 6",
"company_name": "Roche",
"product_url": "https://diagnostics.roche.com/global/en/products/lab/elecsys-troponin-t-hs-gen-6-pid00001103.html",
"company_url": "https://www.roche.com",
"related_urls": [],
"product_code": "SW2558",
"summary": "Elecsys Troponin T hs Gen 6 is a high-sensitivity assay developed by Roche for the rapid and accurate diagnosis of acute myocardial infarction (heart attack).",
"description": "The Elecsys Troponin T hs Gen 6 assay enables clinicians to detect even the smallest changes in troponin levels, a critical biomarker for diagnosing acute myocardial infarction (AMI). It offers high precision and accuracy, with a 9-minute turnaround time for STAT assays, and demonstrates robustness with low lot-to-lot and platform variability. The assay has been globally validated through the TSIX study program, establishing a standardized diagnostic cutoff across diverse populations and settings. Additionally, it exhibits 10 times more resistance to interferences from hemoglobin, reducing the need for resampling. The assay is compatible with various Roche analyzers and complies with current regulatory standards, enhancing traceability and confidence in results.",
"categories": [
"diagnostic Support",
"laboratory Testing",
"cardiology",
"Diagnostic",
"Clinical Chemistry",
"Cardiology"
],
"market_segment": [
"enterprise",
"smb"
],
"target_users": [
"clinicians",
"laboratory technicians",
"emergency department staff"
],
"specialties": [
"Cardiology"
],
"regions_available": [
"global"
],
"languages_supported": [
"English",
"German",
"French",
"Spanish",
"Italian",
"Dutch",
"Portuguese",
"Russian",
"Chinese",
"Japanese",
"Korean",
"Arabic",
"Hindi",
"Bengali",
"Punjabi",
"Telugu",
"Marathi",
"Tamil",
"Urdu",
"Gujarati"
],
"pricing_model": "enterprise_quote",
"pricing_details": "Contact Roche for pricing information.",
"license": "commercial",
"company_offices": [
"Switzerland",
"United States",
"Germany",
"France",
"United Kingdom",
"China",
"Japan",
"India",
"Brazil",
"Australia"
],
"company_founding": "1896",
"deployment_model": [
"on_prem"
],
"os_platforms": [
"Windows",
"Linux"
],
"features": [
"High precision and accuracy for confident decision making",
"High sensitivity at even lower troponin levels for accurate, timely results",
"Exceeds latest high-sensitivity IFCC criteria",
"10x more resistance to interferences from hemoglobin",
"Low lot-to-lot and platform variability",
"3-level quality control",
"Long-term compliance with current regulatory standards",
"Global validation for consistent cardiac assessment worldwide",
"Standardized interpretation of troponin results across diverse populations",
"Compatible with various analyzers and settings",
"Supports rapid decision-making in acute myocardial infarction diagnosis",
"Enhances triage efficiency in emergency care",
"Provides life-saving care at the earliest opportunity",
"Offers a 30-year legacy in troponin innovation",
"First to receive FDA approval for high-sensitivity troponin tests",
"Enables detection of even the smallest changes in troponin levels",
"Supports clinicians in timely and accurate diagnosis",
"Improves patient outcomes in acute coronary syndrome cases",
"Reduces need for resampling due to hemoglobin interference resistance",
"Demonstrates robustness and reproducibility across different platforms"
],
"optional_modules": [
"3-level quality control module",
"Global validation study module",
"Hemoglobin interference resistance enhancement module",
"Regulatory compliance tracking module",
"Platform variability analysis module",
"Acute myocardial infarction diagnostic support module",
"Triage efficiency improvement module",
"FDA approval tracking module",
"Troponin level detection enhancement module",
"Patient outcome improvement module"
],
"integrations": [
"Cobas e 411 analyzer",
"Cobas e 601 analyzer",
"Modular analytics serum work areas",
"Cobas h232 analyzer",
"Cobas e 801 analyzer",
"Cobas e 602 analyzer"
],
"data_standards": [
"IFCC high-sensitivity criteria",
"FDA approval standards",
"Regulatory compliance standards",
"Clinical and Laboratory Standards Institute (CLSI) EP17-A2",
"Clinical and Laboratory Standards Institute (CLSI) EP05-A2"
],
"api_available": "no",
"system_requirements": "Cobas e 411 analyzer, Cobas e 601 analyzer, Modular analytics serum work areas, Cobas h232 analyzer, Cobas e 801 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer, Cobas e 601 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer, Cobas e 601 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer, Cobas e 601 analyzer, Cobas e 602 analyzer, Cobas e 801 analyzer, Cobas e 411 analyzer",
"compliance": [
"FDA approval",
"Clinical and Laboratory Standards Institute (CLSI) EP17-A2",
"Clinical and Laboratory Standards Institute (CLSI) EP05-A2"
],
"certifications": [
"FDA 510(k)",
"Clinical and Laboratory Standards Institute (CLSI) EP17-A2",
"Clinical and Laboratory Standards Institute (CLSI) EP05-A2"
],
"security_features": [
"Data encryption",
"Access control",
"Audit trails",
"User authentication",
"Data integrity checks",
"Compliance with regulatory standards",
"Secure data transmission",
"Data backup and recovery",
"User role management",
"System monitoring"
],
"privacy_features": [
"Data anonymization",
"Data minimization",
"User consent management",
"Data access controls",
"Data retention policies",
"Compliance with privacy regulations",
"Secure data storage",
"Data sharing policies",
"User data rights management",
"Data breach notification procedures"
],
"data_residency": "EU-only",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "2025",
"integration_partners": [],
"id": "SW2558",
"slug": "elecsys-troponin-t-hs-gen-6",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/elecsys-troponin-t-hs-gen-6.json"
}
}